DNAJC5 and ovarian cancer: As presented in a companion research article in this Cells Special Issue, the investigation into the effects of a novel anti-CSP antibody in ovarian cancer revealed a dramatic decrease in tumor growth in ovarian cancer murine models and unraveled a wealth of anti-tumor mechanisms associated with anti-CSP treatment [98].